VHL vitasora health limited

VHL - Virax aids trial

  1. 1,458 Posts.
    lightbulb Created with Sketch. 23
    Virax Holdings is another biotech that has just bounced
    off it's lows(up 4c to 52c today on low volume). On Tuesday it announced that it had recruited patients for it's HIV treatment trial. The results aren't out until November/December but at these levels there can't
    be much downside so I got some as a medium term hold.
    Apparently Virax's treatment kills the AIDS virus rather
    than just suppressing it as in most other treatments so
    it eliminates the need for drugs to be taken indefinitely. Probably a risky investment but with a BIG upside
    on a successful trial.
    I hold VHL. Do your own research before investing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.9¢
Change
0.002(7.41%)
Mkt cap ! $49.83M
Open High Low Value Volume
2.7¢ 3.0¢ 2.6¢ $39.56K 1.411M

Buyers (Bids)

No. Vol. Price($)
2 141852 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 723823 2
View Market Depth
Last trade - 15.59pm 12/09/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.